“There are more options for recommendations now, so you must have the rationale and substantiation for each of those options,” said Ralph P. Tufano, MD, MBA, the Charles W. Cummings MD Professor and director of the division of head and neck endocrine surgery in the department of otolaryngology-head and neck surgery at Johns Hopkins University School of Medicine in Baltimore.
Dr. Zafereo believes that the timing of the update is ideal. “Thyroid cancer incidence in the United States, particularly well-differentiated thyroid cancer, has nearly doubled since the last ATA guidelines were published in 2009,” he said. “Studies have predicted that thyroid cancer may be the third most common cancer diagnosed among women by 2020, with economic impact of $20 billion. Much of this increase is attributable to increased incidental diagnosis of thyroid nodules and cancer on imaging and pathology.”
Revised guidelines for thyroid nodule management include recommendations on: